CogniCurrent Icon

COGNICURRENT

A compact global news feed for the bigger picture.

Regions
Topics
Saved views:
Save your current filters to revisit or share.
29 stories
🇧🇷 Folha (PT)
National & Local

Research on new medications, such as polylaminin, must follow strict international rules

The development of new medications, including polylaminin, requires adherence to strict international guidelines, particularly in clinical trials that involve control groups to assess efficacy and safety.

Feb 26 • 14:09 UTC
🇧🇷 Folha (PT)
Life & Tech

Polylaminin is promising, but must overcome clinical trials

Polylaminin shows promise as a potential treatment for severe spinal injuries but faces significant challenges in clinical testing.

Feb 26 • 01:00 UTC
🇧🇷 Folha (PT)
National & Local

How long will it take for us to know the effectiveness of polylaminin? Understand the substance in 16 topics

Polylaminin has generated significant attention on social media due to its association with reports of patient recovery, but experts urge caution due to a lack of robust clinical evidence supporting its efficacy and safety.

Feb 25 • 21:45 UTC
🇧🇷 G1 (PT)
National & Local

Delegate who survived accident with police vehicle receives dose of polylaminin in an attempt to walk again

Delegate Leonardo Sanches, paralyzed after a car accident, has received polylaminin treatment, becoming the first individual in Goiás to access this potentially life-altering therapy.

Feb 25 • 11:45 UTC
🇧🇷 G1 (PT)
National & Local

Polylaminin: How the studies were conducted, what are the results so far, and what does Anvisa say? Understand

A groundbreaking Brazilian study on polylaminin shows promising results in restoring movement after severe injuries, with a pivotal clinical study approved by Anvisa set to begin next month.

Feb 25 • 03:01 UTC
🇧🇷 G1 (PT)
National & Local

'Something told me to move my foot': a patient with spinal injury describes how he regained movement after the application of polylaminin

A recent study on polylaminin shows promise in reconnecting spinal cords, as illustrated by the case of a patient who regained movement after treatment.

Feb 24 • 06:00 UTC
🇧🇷 Folha (PT)
National & Local

Don't treat polylaminin as if it were the national team

The article discusses the recent hype surrounding polylaminin, a substance believed to regenerate spinal cord injuries, and its political implications in Brazil.

Feb 23 • 23:30 UTC
🇧🇷 G1 (PT)
National & Local

It’s #FAKE profile on Instagram that pretends to be Tatiana Sampaio, researcher of polylaminin

A fake Instagram profile impersonating Tatiana Sampaio, a researcher from UFRJ, has been identified, misleading followers with false information about her work.

Feb 23 • 20:40 UTC
🇧🇷 Folha (PT)
National & Local

Polylaminin researcher will receive a medal from the government of Espírito Santo

Tatiana Sampaio, a researcher from UFRJ, will be awarded the Jerônimo Monteiro medal by the Espírito Santo government for her work on polylaminin, a molecular treatment for spinal cord injuries.

Feb 23 • 19:31 UTC
🇧🇷 G1 (PT)
National & Local

Polylaminin: Maranhão native who received the substance begins home treatment and shows improvement

Hector Lucena, a 26-year-old agronomy student from Balsas, Maranhão, has begun at-home treatment with polylaminin for spinal cord trauma and reports improvements in his health.

Feb 23 • 17:28 UTC
🇧🇷 G1 (PT)
National & Local

Patient from Sergipe receives treatment with polylaminin

A 27-year-old woman from Sergipe has received a groundbreaking treatment involving polylaminin, which may restore movement to individuals with paraplegia or quadriplegia.

Feb 23 • 16:38 UTC
🇧🇷 G1 (PT)
National & Local

Polylaminin: Tetraplegic athlete from Paraná applies compound that 'trended' with positive motor recovery results

A tetraplegic athlete in Brazil has seen positive results from an experimental treatment using polylaminin, a compound derived from a protein produced in the human body.

Feb 23 • 15:29 UTC
🇧🇷 G1 (PT)
National & Local

VIDEO: Reporter Flávia Cintra hugs biologist Tatiana Sampaio, researcher leading studies on polylaminin

Reporter Flávia Cintra shares an emotional moment with biologist Tatiana Sampaio during a segment on the substance polylaminin, which offers hope for those with spinal cord injuries, going viral on social media.

Feb 23 • 14:26 UTC
🇧🇷 G1 (PT)
National & Local

VIDEOS: Good Morning Minas, Monday, February 23, 2026

The article covers various topics such as severe weather in Brazil, a substance called polylaminin that reconnects the spinal cord, state football matches, legal cases involving exploitation of minors, and political tensions related to Bolsonaro.

Feb 23 • 10:30 UTC
🇧🇷 G1 (PT)
National & Local

Polylaminin: the substance that 'reconnects' the spinal cord and brings hope to people with paraplegia

Polylaminin is a new substance being researched in Brazil that shows promise for reconnecting the spinal cord and providing hope for individuals suffering from paraplegia.

Feb 22 • 23:47 UTC
🇧🇷 G1 (PT)
National & Local

This is Fantastic: the advances in experimental treatments with polylaminin

The article discusses promising advancements in experimental treatments involving polylaminin, a placenta-derived protein that may restore movement in patients with severe spinal cord injuries.

Feb 22 • 20:39 UTC
🇧🇷 G1 (PT)
National & Local

VIDEO: João Gomes interrupts show in Sapucaí to honor scientist leading research on polylaminin

Singer João Gomes interrupted a performance to pay tribute to researcher Tatiana Sampaio, who is recognized for her work on polylaminin for treating acute spinal cord injuries.

Feb 22 • 16:50 UTC
🇧🇷 G1 (PT)
National & Local

Polylaminin: student from Balsas is the second patient in MA to receive the substance

Hector Lucena, a 26-year-old agriculture student from Balsas, became the second person in Maranhão to receive polylaminin during an experimental procedure on November 21.

Feb 21 • 18:59 UTC
🇧🇷 Folha (PT)
National & Local

Scientific societies call for caution and precision in the debate over poly-laminin

Scientific societies in Brazil urge caution in the discussion surrounding poly-laminin, a protein under investigation for spinal cord injury regeneration, emphasizing the importance of distinguishing experimental research from established clinical application.

Feb 21 • 15:51 UTC
🇧🇷 Folha (PT)
National & Local

Polylaminin and Tatiana Sampaio go viral on social media, but fall well below Virginia, says survey

Biologist Tatiana Sampaio has gained 16 million interactions on social media, receiving significant attention for her research on polylaminin, a protein aimed at aiding spinal cord injury regeneration.

Feb 20 • 19:21 UTC
🇧🇷 G1 (PT)
National & Local

Tatiana Sampaio at IFTM in Patrocínio: how to participate in the event with the scientist who developed a molecule that can reverse spinal injuries

Tatiana Sampaio will be speaking at the IFTM in Patrocínio on March 12, focusing on her research that could aid recovery from spinal injuries.

Feb 20 • 19:15 UTC
🇧🇷 G1 (PT)
World

Daily recap #1868: Argentina's Chamber approves labor reform, which returns to the Senate; US Supreme Court decides on legality of Trump's tariff; The steps of experimental treatment with polylaminin

Argentina's Chamber of Deputies has approved a labor reform which now goes back to the Senate, while the US Supreme Court is set to rule on Trump's tariff legality, and a patient has regained ability to walk thanks to a new treatment with polylaminin.

Feb 20 • 11:38 UTC
🇧🇷 G1 (PT)
National & Local

Patient walks again and polylaminin trends; understand what the substance can do and what is still unknown

Polylaminin has recently gained attention on social media due to a patient's recovery and ongoing discussions about its potential and patent issues in Brazil.

Feb 20 • 06:00 UTC
🇧🇷 G1 (PT)
National & Local

First maranhense to receive polylaminin, shot PM shows improvement

Military police officer Romildo Leobino is showing signs of improvement after undergoing an experimental treatment with polylaminin following his injury during an operation.

Feb 19 • 12:11 UTC
🇧🇷 G1 (PT)
National & Local

Polylaminin: student shot inside school in PI cannot participate in innovative treatment

João Lucas Campelo, a 17-year-old student who became quadriplegic after being shot, is unable to undergo an experimental polylaminin treatment due to his health condition and other constraints.

Feb 16 • 20:10 UTC
🇧🇷 Folha (PT)
National & Local

Three patients who received polylaminin by court order die in RJ, PR, and ES

Three patients who received polylaminin as part of a court order have died in Brazil, with deaths attributed to pre-existing medical issues, according to the producing laboratory.

Feb 13 • 00:11 UTC
🇧🇷 G1 (PT)
National & Local

Youngest patient in the country to receive polylaminin reports movement in his hands: 'I couldn't move before'

Luiz Otávio Santos Nunez, the youngest patient in Brazil to receive polylaminin, reports regaining some movement in his fingers following the experimental treatment after a serious injury.

Feb 8 • 05:00 UTC
🇧🇷 G1 (PT)
Life & Tech

Polylaminin: a molecule discovered in Brazil 'by chance' that became hope to reverse spinal cord injuries

Polylaminin, a modified version of the naturally occurring laminin protein, is being studied as a new potential treatment for spinal cord injury victims in Brazil, although it is still in early clinical trial phases.

Feb 2 • 20:00 UTC
🇧🇷 Folha (PT)
Life & Tech

Podcast: the Brazilian experimental drug that may be hope for spinal cord injuries

The podcast discusses polylaminin, an experimental drug showing promise in restoring movement for patients with spinal cord injuries, highlighted by the case of a Brazilian influencer who regained arm movement after treatment.

Feb 2 • 08:00 UTC

Story in context

Loading Intelligence...

📡

Select a report from the feed to view analysis and related coverage.